VIGILANT LABORATORIES LLC

PINECREST, FL

OncologymRNAGrant-only

Compare Sign in to watch

What changed

NIH R35 · $0.7M · Chemoenzymatic strategies for synthesizing glycans and glycoconjugates

5w agoNew grantJun 10, 2026Source filing (opens the source filing in a new tab)

Momentum

86no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R35 · $676k · non-dilutive
Jul 1, 2026
UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, XI · NIGMS · award ends Apr 30, 2031 · Chemoenzymatic strategies for synthesizing glycans and glycoconjugates
NIH RePORTER · NIH RePORTER 11331750 (opens the source filing in a new tab)
Grant
R01 · $654k · non-dilutive
Mar 16, 2026
UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ZHANG, RUGANG · NCI · award ends Feb 28, 2031 · Mechanistic basis and therapeutic strategies for PPP2R1A mutation in gynecological cancer
NIH RePORTER · NIH RePORTER 11271226 (opens the source filing in a new tab)
Grant
P01 · $401k · non-dilutive
Feb 1, 2026
UNIVERSITY OF PENNSYLVANIA · PI ZHANG, RUGANG · NIA · award ends Jan 31, 2031 · Project 4: Chromatin basis of cellular senescence and tissue aging
NIH RePORTER · NIH RePORTER 11096622 (opens the source filing in a new tab)
Grant
R44 · $1.0M · non-dilutive
Sep 1, 2025
VIGILANT LABORATORIES LLC · PI FRANZMANN, ELIZABETH J · NCI · award ends Aug 31, 2027 · Development of an effective, low-cost, point-of-care early detection test for oral cancer in low resource settings
NIH RePORTER · NIH RePORTER 11069154 (opens the source filing in a new tab)
Grant
R21 · $205k · non-dilutive
Nov 15, 2024
MCLEAN HOSPITAL · PI CHEN, XI · NIMH · award ends Oct 31, 2026 · Observing brain lactate dynamics during a working memory task in first episode and chronic schizophrenia
NIH RePORTER · NIH RePORTER 11232294 (opens the source filing in a new tab)
Grant
R01 · $445k · non-dilutive
Nov 1, 2024
UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHEN, XI · NHLBI · award ends Jan 31, 2027 · Mechanism and Function of Endoplasmic Reticulum Protein Quality Control Machinery In The Maintenance of Hematopoietic Stem Cells
NIH RePORTER · NIH RePORTER 11199055 (opens the source filing in a new tab)
Grant
R01 · $656k · non-dilutive
May 1, 2024
UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AHRENS, ERIC T. · NCI · award ends Apr 30, 2029 · Imaging tumor-associated macrophages in head and neck squamous cell carcinoma using fluorine-19 MRI
NIH RePORTER · NIH RePORTER 11319716 (opens the source filing in a new tab)
Grant
R01 · $656k · non-dilutive
Jun 1, 2023
UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AHRENS, ERIC T. · NCI · award ends May 31, 2027 · Metallo-fluorocarbon nanoemulsion for PET detection of cancer inflammation
NIH RePORTER · NIH RePORTER 11345750 (opens the source filing in a new tab)
Grant
R01 · $527k · non-dilutive
Dec 1, 2022
UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHEN, XI · NCI · award ends May 31, 2028 · Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
NIH RePORTER · NIH RePORTER 11288770 (opens the source filing in a new tab)
Grant
R01 · $527k · non-dilutive
Dec 1, 2022
UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHEN, XI · NCI · award ends May 31, 2028 · Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
NIH RePORTER · NIH RePORTER 11406331 (opens the source filing in a new tab)
Grant
R01 · $498k · non-dilutive
Aug 1, 2022
UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ZHANG, RUGANG · NCI · award ends Nov 30, 2027 · Metabolic basis of ARID1A-mutated ovarian cancer
NIH RePORTER · NIH RePORTER 11225083 (opens the source filing in a new tab)
Grant
R01 · $715k · non-dilutive
Jul 1, 2022
YALE UNIVERSITY · PI CHEN, XI · NIA · award ends May 31, 2027 · A Life Course Approach to Understanding Racial and Ethnic Disparities in Alzheimer's Disease and Related Dementias and Health Care
NIH RePORTER · NIH RePORTER 11128581 (opens the source filing in a new tab)
Grant
R01 · $734k · non-dilutive
Mar 10, 2016
DUKE UNIVERSITY · PI TOTH, CYNTHIA ANN · NEI · award ends May 31, 2030 · Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
NIH RePORTER · NIH RePORTER 11374353 (opens the source filing in a new tab)
Grant
R01 · $374k · non-dilutive
Dec 1, 2015
UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ZHANG, RUGANG · NCI · award ends Jan 31, 2027 · Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer
NIH RePORTER · NIH RePORTER 11257731 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the grant record at 0.28same therapeutic area

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH R35 · $0.7M · Chemoenzymatic strategies for synthesizing glycans and glycoconjugates
5w agoNew grantSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
6w agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Metallo-fluorocarbon nanoemulsion for PET detection of cancer inflammation
7w agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Imaging tumor-associated macrophages in head and neck squamous cell carcinoma using fluorine-19 MRI
2mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Mechanistic basis and therapeutic strategies for PPP2R1A mutation in gynecological cancer
4mo agoNew grantSource (opens the source filing in a new tab)
NIH R21 · $0.2M · Observing brain lactate dynamics during a working memory task in first episode and chronic schizophrenia
5mo agoGrant renewalSource (opens the source filing in a new tab)
NIH P01 · $0.4M · Project 4: Chromatin basis of cellular senescence and tissue aging
5mo agoNew grantSource (opens the source filing in a new tab)
NIH R01 · $0.4M · Mechanism and Function of Endoplasmic Reticulum Protein Quality Control Machinery In The Maintenance of Hematopoietic Stem Cells
5mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.4M · Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer
6mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Metabolic basis of ARID1A-mutated ovarian cancer
7mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · A Life Course Approach to Understanding Racial and Ethnic Disparities in Alzheimer's Disease and Related Dementias and Health Care
10mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R44 · $1.0M · Development of an effective, low-cost, point-of-care early detection test for oral cancer in low resource settings
10mo agoNew grantSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

R35 · $676k · non-dilutive

R01 · $654k · non-dilutive

P01 · $401k · non-dilutive

R44 · $1.0M · non-dilutive

R21 · $205k · non-dilutive

R01 · $445k · non-dilutive

R01 · $656k · non-dilutive

R01 · $656k · non-dilutive

R01 · $527k · non-dilutive

R01 · $527k · non-dilutive

R01 · $498k · non-dilutive

R01 · $715k · non-dilutive

R01 · $734k · non-dilutive

R01 · $374k · non-dilutive